Pentosidine - A new biochemical marker in diabetic retinopathy

Ophthalmic Research

Volumn 42, Issue 2, 2009, Pages 96-98

  Salman, Abdelrahman Gaber ^a   Mansour, Dina Ezzat Abdel Aziz ^a   Swelem, Al Hussein Ali ^a   Al Zawahary, Walid Mohamed Abdel Raaouf ^a   Radwan, Ahmad Abdelmegid ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Diabetic retinopathy; Pentosidine

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; PENTOSIDINE; PROTEIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; OPHTHALMOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ARGININE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LYSINE; MALE; MIDDLE AGED;

EID: 67449131986     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000225661     Document Type: Article

References (10)

1. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002;105:1135-1143.
2. Sell DR, Monnier V: Structure elucidation of a senescence cross-link from human extracellular matrix: implication of pentosis in the ageing process. J Biol Chem 1989;264:21597-21602.
3. Jakus V, Rietbrock N: Advanced glycation end products and the progress of diabetic vascular complications. Physiol Res 2004;53:131-142. (Pubitemid 38525116)
4. Jeppsson JO, Jerntorp P, Sundkvist G, Englund H, Nylund V: Measurement of haemoglobin A1c by a new liquid chromatographic assay: methodology, clinical utility and relation to glucose tolerance elevated. Clin Chem 1986;32:1867-1872. (Pubitemid 17018062)
5. Miyata T, Ueda Y, Shinzato T: Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end stage renal failure: renal implications in the pathophysiology of pentosidine. J Am Soc Nephrol 1996;7:1198-1206. (Pubitemid 27468273)
6. Refaie MR: Prevention of type 2 diabetes mellitus. Proc 12th Int Sci Congr Egypt Med Synd, 2000, p 48.
7. Hassan A, Kissebah AH, El Said E, Sittein S, El-Serougy H, Shahin M: Is HLA-DR typing a marker of severity of diabetic retinopathy? Bull Ophthalmol Soc Egypt 2003;96:4.
8. Turk Z, Sesto M, Skodler J, Ferencak G, Pokupec R, Turk N, Stavljenic-Rukavina A: Products of advanced glycation in patients with type 2 diabetes and vascular disease. Ann Clin Biol Chem 2003;40:552-559. (Pubitemid 37152209)
9. Schmidt AM, Yan SD, Wantier JL, Stern D: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999;84:489-497.
10. Schimoike T, Inoguchi T, Umeda F, Nawata H, Kawanok O, Ochi H: The meaning of serum levels of advanced glycation and products in diabetic nephropathy. Metabolism 2000;49:1030-1035. (Pubitemid 30641441)